Intranasal administration of neuropeptide Y; development of a novel treatment for major depressive disorder

被引：0
|
作者：
Mathe, A. A. [1 ]
Berg, E. [1 ]
Michaneck, M. [1 ]
Charney, D. S. [2 ]
Murrough, J. W. [3 ]
机构：
[1] Karolinska Inst, Clin Neurosci, Stockholm, Sweden
[2] Icahn Sch Med Mt Sinai, Off Dean, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Psychiat, New York, NY 10029 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 40卷
关键词：
D O I：
10.1016/j.euroneuro.2020.09.184
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.245
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [1] A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
    Mathe, Aleksander A.
    Michaneck, Miranda
    Berg, Elisabeth
    Charney, Dennis S.
    Murrough, James W.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2020, 23 (12): : 783 - 790
  • [2] Plasma neuropeptide Y in patients with major depressive disorder
    Hashimoto, H
    Onishi, H
    Koide, S
    Kai, T
    Yamagami, S
    [J]. NEUROSCIENCE LETTERS, 1996, 216 (01) : 57 - 60
  • [3] Neuropeptide Y and CRH in Major Depressive Disorder (MDD)
    Mathe, Aleksander A.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 : 12 - 12
  • [4] Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder
    Kryst, Joanna
    Kawalec, Pawel
    Pilc, Andrzej
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) : 9 - 20
  • [5] Plasma Neuropeptide Y Levels in Medication Naive Adolescents with Major Depressive Disorder
    Gulec, Medine Yazici
    Ozalmete, Ozlem Albayrak
    Ozturk, Mucahit
    Gulec, Huseyin
    Sayar, Kemal
    Kose, Samet
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 20 (02): : 132 - 138
  • [6] Neuropeptide y and neuropeptide s in major depressive disorder and post-traumatic stress disorder: Preclinical andclinical studies
    Mathe, A.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S21 - S21
  • [7] Intranasal Administration of Neuropeptide Y in Patients With Posttraumatic Stress Disorder: A Single Ascending Dose Study
    Murrough, James
    Sayed, Seharish
    Van Dam, Nicholas
    Horn, Sarah
    Kautz, Marin
    Costi, Sara
    Collins, Katherine
    Iacoviello, Brian
    Parides, Michael
    Mathe, Aleksander
    Iosifescu, Dan
    Feder, Adriana
    Charney, Dennis
    [J]. NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S122 - S123
  • [8] Neuropeptide Y in plasma during physical exercise test in patients with major depressive disorder
    Andersson, K
    Wisén, AGM
    Wohlfart, B
    Ekman, R
    Westrin, ÅW
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S428 - S429
  • [9] Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
    Gonda, Xenia
    Sharma, Samata R.
    Tarazi, Frank I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (01) : 81 - 89
  • [10] Association study of the neuropeptide Y gene polymorphism and sertraline antidepressant response in major depressive disorder
    Wang, Y.
    Wang, C.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 105 - 105
12345